P/E ratio for RPG Life Sciences (RPGLIFE.NS)
P/E ratio as of April 2024 (TTM): 33.0
According to RPG Life Sciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 33.0102. At the end of 2022 the company had a P/E ratio of 21.6.
P/E ratio history for RPG Life Sciences from 2013 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 21.6 | 7.54% |
| 2021 | 20.1 | 18.75% |
| 2020 | 16.9 | -9.22% |
| 2019 | 18.6 | -50.01% |
| 2018 | 37.3 | -42.53% |
| 2017 | 64.9 | 77.01% |
| 2016 | 36.7 | 2.59% |
| 2015 | 35.7 | -200.86% |
| 2014 | -35.4 | -1928.53% |
| 2013 | 1.94 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.